Sweet Corn and Carotenoids
Effects of Sweet Corn Intake on Carotenoid Levels and Gastrointestinal Wellness
1 other identifier
interventional
40
1 country
1
Brief Summary
This study will assess the effect of daily yellow and white sweet corn intake on serum lutein and zeaxanthin concentrations. Skin carotenoid levels using the Veggie Meter will be assessed, and gastrointestinal symptoms and changes in fecal microbiota during a 4-week intervention period will be monitored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2025
CompletedFirst Posted
Study publicly available on registry
March 24, 2025
CompletedStudy Start
First participant enrolled
May 14, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJanuary 22, 2026
May 1, 2025
12 months
March 21, 2025
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum concentration of lutein + zeaxanthin
Sum of serum concentrations of lutein and zeaxanthin.
28 days
Study Arms (2)
Yellow Sweet Corn
EXPERIMENTAL1.5 cups of yellow sweet corn daily
White Sweet Corn
SHAM COMPARATOR1.5 cups of white sweet corn daily
Interventions
Participants will consume 1.5 cups daily of yellow or white canned sweet corn.
Eligibility Criteria
You may qualify if:
- Adults ≥ 18 years of age
- Able to provide written consent in English
- Baseline Veggie Meter score of ≤ 250 (Scale from 0 to 850)
- Willing to adhere to study procedures
You may not qualify if:
- Baseline Veggie Meter score of \>250
- Corn allergy
- Current use of laxatives or antidiarrheal medications
- Previously or currently being treated for intestinal disease, including irritable bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease, or gastrointestinal cancer
- Previous gastrointestinal surgery (e.g., gastric bypass, fundoplication, bowel resection)
- Current cancer treatment
- Current pregnancy
- Vegetarian diet
- Elite athletes or long-distance runners.
- Use of antibiotic drugs within 1 month of the screening visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Florida
Gainesville, Florida, 32611, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2025
First Posted
March 24, 2025
Study Start
May 14, 2025
Primary Completion
April 30, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 22, 2026
Record last verified: 2025-05